Home > Financial Ratios > BETA DRUGS

BETA DRUGS
EV/Core EBITDA

    Back to All Ratios
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 23.6219.1011.2112.594.85

What is the latest EV/Core EBITDA ratio of BETA DRUGS ?

The latest EV/Core EBITDA ratio of BETA DRUGS is 23.62 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202523.62
Mar202419.10
Mar202311.21
Mar202212.59
Mar20214.85

How is EV/Core EBITDA of BETA DRUGS Trending?

Years EV/Core EBITDA % Change
Mar2025 23.62
23.66
Mar2024 19.1
70.38
Mar2023 11.21
-10.96
Mar2022 12.59
159.59
Mar2021 4.85 -

Other Financial Ratios of BETA DRUGS


Compare EV/Core EBITDA ratio of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,301.4 Cr -1.2% -6.1% 14.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


BETA DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-1.2%

-6.1%

14.1%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses